Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma

NCT01513187 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Advanced Renal Cell Carcinoma

Interventions

DRUG: Pazopanib + interferon alpha 2A

Sponsor

Spanish Oncology Genito-Urinary Group

Collaborators

[object Object]